[Sublingual administration of heparinlipocaic].
D000286:Administration, Sublingual; D001161:Arteriosclerosis / Q000628:therapy*; D005223:Fats / Q000378:metabolism*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D050356:Lipid Metabolism; D008082:Lipotropic Agents / Q000627:therapeutic use*
D005223:Fats; D008082:Lipotropic Agents; D006493:Heparin
ARTERIOSCLEROSIS/therapy; FATS/metabolism; HEPARIN/therapeutic use; LIPOCAIC/therapeutic use
La thérapeutique héparine-lipocaic par administration sublinguale.